Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/31/2023 | EXELIXIS, INC. | EXEL | Grant | | 18.2k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 36.4k | $19.28 | $700.9k | | 05/31/2023 |
06/17/2022 | Liquidia Corp | | Grant | Non-Qualified Stock Option (right to buy) | 20k | $4.86 | $97.2k | | 06/17/2022 |
08/20/2021 | Liquidia Corp | | Grant | Non-Qualified Stock Option (right to buy) | 20k | $2.59 | $51.8k | | 08/20/2021 |
04/13/2021 | Liquidia Corp | | Grant | Stock Option (Right to Buy) | 30k | $2.52 | $75.6k | | 04/13/2021 |
04/13/2021 | Liquidia Corp | | Grant | Stock Option (Right to Buy) | 16.1k | $2.52 | $40.7k | | 04/13/2021 |
11/16/2020 | AMAG PHARMACEUTICALS, INC. | AMAG | Disposition | Stock Option (Right to Buy) | 21.3k | $0.00 | $0 | | 11/16/2020 |
11/16/2020 | AMAG PHARMACEUTICALS, INC. | AMAG | Disposition | Stock Option (Right to Buy) | 9.5k | $0.00 | $0 | | 11/16/2020 |
11/16/2020 | AMAG PHARMACEUTICALS, INC. | AMAG | Disposition | Stock Option (Right to Buy) | 6k | $0.00 | $0 | | 11/16/2020 |
11/16/2020 | AMAG PHARMACEUTICALS, INC. | AMAG | Disposition | Common Stock | 3.5M | $0.00 | $0 | See footnote | 11/16/2020 |
11/16/2020 | AMAG PHARMACEUTICALS, INC. | AMAG | Disposition | Common Stock | 14.7k | $0.00 | $0 | | 11/16/2020 |
06/02/2020 | AMAG PHARMACEUTICALS, INC. | AMAG | Grant | Stock Option (Right to Buy) | 21.3k | $8.52 | $181.4k | | 06/02/2020 |
06/02/2020 | AMAG PHARMACEUTICALS, INC. | AMAG | Grant | Common Stock, par value $0.01 per share ("Common Stock") | 10.3k | $0.00 | $0 | | 06/02/2020 |
10/08/2019 | AMAG PHARMACEUTICALS, INC. | AMAG | Grant | Stock Option (Right to Buy) | 9.5k | $11.58 | $109.5k | | 10/08/2019 |
10/08/2019 | AMAG PHARMACEUTICALS, INC. | AMAG | Grant | Stock Option (Right to Buy) | 6k | $11.58 | $69.5k | | 10/08/2019 |
10/08/2019 | AMAG PHARMACEUTICALS, INC. | AMAG | Grant | Common Stock, par value $0.01 per share ("Common Stock") | 4.4k | $0.00 | $0 | | 10/08/2019 |